Pharmacy owners who wanted to sell their pharmacies for personal reasons, but with no exit strategy — was the impetus behind McKesson’s decision in 2008 to launch RxOwnership.
The use of pharmacy DIR fees has increased by 45,000% between 2010 and 2017, per a letter from Rep. Cathy McMorris Rodgers, R-Wash., to Health and Human Services secretary Alex Azar.
McKesson Prescription Technology Solutions president Nathan Mott said the company has created a broad and deep network throughout the continuum of care.
Alembic has received the FDA ok for generic Vigamox, and Tricore, which have a market value of $68 million, and $92 million, respectively, for the 12 months ending December 2018.
